US Patent Issued to The Regents of the University of California on April 7 for "Compositions and methods for transferrin receptor 1 targeting" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,310, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.).

"Compositions and methods for transferrin receptor 1 targeting" was invented by Manuel L. Penichet (Los Angeles), Tracy R. Wells (Los Angeles), Pierre V. Candelaria (Los Angeles) and Juan C. Almagro (Beverly Hills, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the disclosure relate to transferrin receptor 1 (TfR1)-binding proteins. In some cases, humanized TfR1-binding proteins are described. Embodiments include methods for treating one or more conditions, for example cancer, using a humanized TfR1-binding protein. In some embodi...